{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:49:22Z","timestamp":1783741762036,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,16]]},"DOI":"10.7759\/cureus.105289","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T08:43:13Z","timestamp":1773650593000},"source":"Crossref","is-referenced-by-count":1,"title":["Antibiotic Exposure Patterns and Clinical Outcomes Preceding Clostridioides difficile Infection: A Retrospective Observational Study"],"prefix":"10.7759","author":[{"given":"Kunalsen","family":"Jagatdeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth S","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyanamitra","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumayan","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhransu","family":"Patro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10030299","article-title":"Mortality following Clostridioides difficile infection in Europe: a retrospective multicenter case-control study","volume":"10","author":"Czepiel J","year":"2021","unstructured":"Czepiel J, Krutova M, Mizrahi A, et al.. Mortality following Clostridioides difficile infection in Europe: a retrospective multicenter case-control study. Antibiotics (Basel). 2021, 10:10.3390\/antibiotics10030299","journal-title":"Antibiotics (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224609","article-title":"Direct cost of health care for individuals with community-associated Clostridium difficile infections: a population-based cohort study","volume":"14","author":"Singh H","year":"2019","unstructured":"Singh H, Nugent Z, Walkty A, et al.. Direct cost of health care for individuals with community-associated Clostridium difficile infections: a population-based cohort study. PLoS One. 2019, 14:e0224609. 10.1371\/journal.pone.0224609","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0810-x","article-title":"Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital","volume":"43","author":"Heimann SM","year":"2015","unstructured":"Heimann SM, Vehreschild JJ, Cornely OA, et al.. Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital. Infection. 2015, 43:707-14. 10.1007\/s15010-015-0810-x","journal-title":"Infection"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02176-12","article-title":"Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection","volume":"57","author":"Brown KA","year":"2013","unstructured":"Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013, 57:2326-32. 10.1128\/AAC.02176-12","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401273300406","article-title":"Clostridium difficile colitis","volume":"330","author":"Kelly CP","year":"1994","unstructured":"Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med. 1994, 330:257-62. 10.1056\/NEJM199401273300406","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46 Suppl 1","author":"Owens RC Jr","year":"2008","unstructured":"Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008, 46 Suppl 1:19-31. 10.1086\/521859","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix833","article-title":"Low risk of primary Clostridium difficile infection with tetracyclines: a systematic review and meta-analysis","volume":"66","author":"Tariq R","year":"2018","unstructured":"Tariq R, Cho J, Kapoor S, Orenstein R, Singh S, Pardi DS, Khanna S. Low risk of primary Clostridium difficile infection with tetracyclines: a systematic review and meta-analysis. Clin Infect Dis. 2018, 66:514-22. 10.1093\/cid\/cix833","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1086\/521861","article-title":"Measures to control and prevent Clostridium difficile infection","volume":"46 Suppl 1","author":"Gerding DN","year":"2008","unstructured":"Gerding DN, Muto CA, Owens RC Jr. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis. 2008, 46 Suppl 1:43-9. 10.1086\/521861","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcw134","article-title":"Restrictive antibiotic stewardship associated with reduced hospital mortality in gram-negative infection","volume":"110","author":"Ritchie ND","year":"2017","unstructured":"Ritchie ND, Irvine SC, Helps A, Robb F, Jones BL, Seaton RA. Restrictive antibiotic stewardship associated with reduced hospital mortality in gram-negative infection. QJM. 2017, 110:155-61. 10.1093\/qjmed\/hcw134","journal-title":"QJM"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1086\/422523","article-title":"Effectiveness of environmental and infection control programs to reduce transmission of Clostridium difficile","volume":"39","author":"Apisarnthanarak A","year":"2004","unstructured":"Apisarnthanarak A, Zack JE, Mayfield JL, et al.. Effectiveness of environmental and infection control programs to reduce transmission of Clostridium difficile. Clin Infect Dis. 2004, 39:601-2. 10.1086\/422523","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060629","article-title":"Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis","volume":"64","author":"Cadle RM","year":"2007","unstructured":"Cadle RM, Mansouri MD, Logan N, Kudva DR, Musher DM. Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm. 2007, 64:2359-63. 10.2146\/ajhp060629","journal-title":"Am J Health Syst Pharm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00135-23","article-title":"Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options","volume":"37","author":"Di Bella S","year":"2024","unstructured":"Di Bella S, Sanson G, Monticelli J, et al.. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. Clin Microbiol Rev. 2024, 37:0013523. 10.1128\/cmr.00135-23","journal-title":"Clin Microbiol Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2017.08.017","article-title":"Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection","volume":"98","author":"Cao F","year":"2018","unstructured":"Cao F, Chen CX, Wang M, et al.. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection. J Hosp Infect. 2018, 98:4-13. 10.1016\/j.jhin.2017.08.017","journal-title":"J Hosp Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa545","article-title":"Acid suppression medications during hospitalization as a risk factor for recurrence of Clostridioides difficile infection: systematic review and meta-analysis","volume":"73","author":"Mehta P","year":"2021","unstructured":"Mehta P, Nahass RG, Brunetti L. Acid suppression medications during hospitalization as a risk factor for recurrence of Clostridioides difficile infection: systematic review and meta-analysis. Clin Infect Dis. 2021, 73:62-8. 10.1093\/cid\/ciaa545","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11233048","article-title":"Improving antimicrobial stewardship program using the Lean Six Sigma methodology: a descriptive study from Mediclinic Welcare Hospital in Dubai, the UAE","volume":"11","author":"Sallam M","year":"2023","unstructured":"Sallam M, Snygg J. Improving antimicrobial stewardship program using the Lean Six Sigma methodology: a descriptive study from Mediclinic Welcare Hospital in Dubai, the UAE. Healthcare (Basel). 2023, 11:10.3390\/healthcare11233048","journal-title":"Healthcare (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa124","article-title":"Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study","volume":"72","author":"Brown KA","year":"2021","unstructured":"Brown KA, Langford B, Schwartz KL, Diong C, Garber G, Daneman N. Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study. Clin Infect Dis. 2021, 72:836-44. 10.1093\/cid\/ciaa124","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27 Suppl 2","author":"van Prehn J","year":"2021","unstructured":"van Prehn J, Reigadas E, Vogelzang EH, et al.. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021, 27 Suppl 2:1-21. 10.1016\/j.cmi.2021.09.038","journal-title":"Clin Microbiol Infect"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5009\/gnl18071","article-title":"Recurrent Clostridium difficile Infection: risk factors, treatment, and prevention","volume":"13","author":"Song JH","year":"2019","unstructured":"Song JH, Kim YS. Recurrent Clostridium difficile Infection: risk factors, treatment, and prevention. Gut Liver. 2019, 13:16-24. 10.5009\/gnl18071","journal-title":"Gut Liver"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr508","article-title":"Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics","volume":"67","author":"Hensgens MP","year":"2012","unstructured":"Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012, 67:742-8. 10.1093\/jac\/dkr508","journal-title":"J Antimicrob Chemother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"Stevens V","year":"2011","unstructured":"Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011, 53:42-8. 10.1093\/cid\/cir301","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1086\/382084","article-title":"Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem","volume":"38","author":"Gerding DN","year":"2004","unstructured":"Gerding DN. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis. 2004, 38:646-8. 10.1086\/382084","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1086\/521863","article-title":"Clinical recognition and diagnosis of Clostridium difficile infection","volume":"46 Suppl 1","author":"Bartlett JG","year":"2008","unstructured":"Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008, 46 Suppl 1:12-8. 10.1086\/521863","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.09.013","article-title":"Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?","volume":"124","author":"Krutova M","year":"2022","unstructured":"Krutova M, Wilcox M, Kuijper E. Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?. Int J Infect Dis. 2022, 124:118-23. 10.1016\/j.ijid.2022.09.013","journal-title":"Int J Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.10.031","article-title":"Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study","volume":"133","author":"Eckart A","year":"2020","unstructured":"Eckart A, Struja T, Kutz A, et al.. Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. Am J Med. 2020, 133:713-722.e7. 10.1016\/j.amjmed.2019.10.031","journal-title":"Am J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/85.4.599","article-title":"The role of albumin in critical illness","volume":"85","author":"Nicholson JP","year":"2000","unstructured":"Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000, 85:599-610. 10.1093\/bja\/85.4.599","journal-title":"Br J Anaesth"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(89)92803-1","article-title":"Protein-losing enteropathy associated with Clostridium difficile infection","volume":"1","author":"Rybolt AH","year":"1989","unstructured":"Rybolt AH, Bennett RG, Laughon BE, Thomas DR, Greenough WB, Bartlett JG. Protein-losing enteropathy associated with Clostridium difficile infection. Lancet. 1989, 1:1353-5. 10.1016\/s0140-6736(89)92803-1","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2014.08.015","article-title":"Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China","volume":"30","author":"Huang H","year":"2014","unstructured":"Huang H, Wu S, Chen R, Xu S, Fang H, Weintraub A, Nord CE. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. Anaerobe. 2014, 30:65-9. 10.1016\/j.anaerobe.2014.08.015","journal-title":"Anaerobe"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.04.008","article-title":"Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia","volume":"73","author":"Chalmers JD","year":"2016","unstructured":"Chalmers JD, Akram AR, Singanayagam A, Wilcox MH, Hill AT. Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia. J Infect. 2016, 73:45-53. 10.1016\/j.jinf.2016.04.008","journal-title":"J Infect"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.60551","article-title":"From protection to prevention: redefining vaccines in the context of antimicrobial resistance","volume":"16","author":"Sallam M","year":"2024","unstructured":"Sallam M, Snygg J, Allam D, Kassem R. From protection to prevention: redefining vaccines in the context of antimicrobial resistance. Cureus. 2024, 16:60551. 10.7759\/cureus.60551","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/472411-antibiotic-exposure-patterns-and-clinical-outcomes-preceding-clostridioides-difficile-infection-a-retrospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T08:43:17Z","timestamp":1773650597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/472411-antibiotic-exposure-patterns-and-clinical-outcomes-preceding-clostridioides-difficile-infection-a-retrospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.105289","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}